Olorofim

N/A

Report date: 2026/03/15 20:00:14
NMEQIDP

Base Information

Drug NameOlorofim
Drug Alias NameF-901318
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDihydroorotate dehydrogenase inhibitors
TargetsDihydroorotate dehydrogenase
Therapy Area/IndicationsRenal InsufficiencyMeningitisHepatic Insufficiency +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumCanadaUnited States +[24] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesF2g Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShionogi & Co LtdShionogi Co LtdF2G Biotech GmbH
Inactive CompaniesF2g Ltd
Active IndicationsRenal InsufficiencyMeningitisHepatic Insufficiency +[6] 
Inactive IndicationsLeukemia, Myeloid, AcuteInvasive Pulmonary Aspergillosis

Other Information

ATC CodeN/A
Related LinksN/A